share_log

华润双鹤(600062.SH):喷他佐辛注射液通过仿制药质量和疗效一致性评价

China Resources Double-Crane Pharmaceutical (600062.SH): The injection of Pethidine hydrochloride has passed the consistency evaluation of generics in terms of quality and efficacy.

Gelonghui Finance ·  Dec 30, 2024 16:54

On December 30, Gelonghui reported that China Resources Double-Crane Pharmaceutical (600062.SH) announced that the company has received the "Drug Supplement Application Approval Notification" (Notification Number: 2024B06197) issued by the National Medical Products Administration for the drug pentazocine injection (referred to as "the pharmaceutical"). Pentazocine injection is suitable for various types of chronic severe pain, such as cancer pain, traumatic pain, postoperative pain, and it can also be used for preoperative or pre-anesthesia administration as an auxiliary medication for surgical anesthesia.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment